This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.
Original paper

Reduced Apolipoprotein M and Adverse Outcomes Across the Spectrum of Human Heart Failure

Volume: 141, Issue: 18, Pages: 1463 - 1476
Published: Apr 2, 2020
Abstract
Background: Apo (apolipoprotein) M mediates the physical interaction between high-density lipoprotein (HDL) particles and sphingosine-1-phosphate (S1P). Apo M exerts anti-inflammatory and cardioprotective effects in animal models. Methods: In a subset of PHFS (Penn Heart Failure Study) participants (n=297), we measured apo M by Enzyme-Linked ImmunoSorbent Assay (ELISA). We also measured total S1P by liquid chromatography–mass spectrometry and...
Paper Details
Title
Reduced Apolipoprotein M and Adverse Outcomes Across the Spectrum of Human Heart Failure
Published Date
Apr 2, 2020
Volume
141
Issue
18
Pages
1463 - 1476
© 2025 Pluto Labs All rights reserved.
Step 1. Scroll down for details & analytics related to the paper.
Discover a range of citation analytics, paper references, a list of cited papers, and more.